Menu

In 2014

Preimplantation Genetic Diagnosis International Society (PGDIS) Annual Meeting

Date and venue: 29th April – 2nd May 2014, University of Kent, Canterbury, UK 

PGDIS 2014 will include the following themes:

  • Biology of PGD: Next generation sequencing, fate mapping, single cell analysis, origins of human development
  • Time-lapse: A useful tool for PGD?
  • At the cutting edge of PGD: Latest technologies for biopsy, freezing and molecular diagnostics
  • The science behind PGD-A: Aneuploidy, meiosis, mosaicism, DNA damage, culture conditions, sperm factors
  • Omics corner: Can metabolomics and transcriptomics complement or replace PGD in practice
  • Clinical experience of PGD: Dashboard of latest developments and results from around the globe
  • The ethics and legalities of PGD: Why are we doing what we're doing and should there be limits?
  • The 25th year of PGD: The start of a 1 year celebration that will culminate in Chicago for PGDIS 2015

For more information, plase read the attached pdf or visit http://www.pgdis.org/

The 7th Advanced Course in Embryology

Date and venue: June 28th, 2014, Munich, Germany

A course developed by Serono Symposia International Foundation in collaboration with Alpha.

The 2014 live educational course will be dedicated exclusively to the most important aspects of ART laboratory procedures, providing a comprehensive view of advanced techniques.

One of the topics is embryo culture media. The fundamental role of the laboratory and therefore the culture media has been to support preimplantation embryo development and to maintain the inherent viability of the gametes/embryos before replacement to the mother. Over the last 10-15 years there have been major advancements in this area, with culture media having developed from simple salt solutions into highly complex defined media, specifically designed to reduce stress to the embryo and maintain high pregnancy rates. Preimplantation Genetic

Screening (PGS) seeks to improve the efficiency of ART by ensuring that the embryos chosen for transfer are chromosomally adequate (euploid). The principle behind it is that, since numerical chromosomal abnormalities in the embryo are the causes of most pregnancy losses, and it is established that a large proportion of the human embryos are aneuploid, the selective replacement of euploid embryos should increase the chances of a successful IVF treatment. Future prospectives are based on SET (single embryo transfer) that needs to be adopted as standard procedure, in order to reduce risks to mother and fetus associated with multiple implantations. Methods for selecting topquality embryos must continue to improve and must be communicated through embryologist education. Criteria and scoring for assessing embryo quality need to be firmly established and followed internationally.

The aim is to give participants both the latest knowledge and the opportunity to share their experiences with renowned scientists and embryologists.

For more information, please read the attached pdf or visit the webpages of the Serono Symposia International Foundation.